HNRNPL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.888300E-02
Normal-vs-Stage2
4.863600E-01
Normal-vs-Stage3
2.326000E-01
Normal-vs-Stage4
3.376400E-01
Stage1-vs-Stage2
1.698600E-01
Stage1-vs-Stage3
8.178600E-01
Stage1-vs-Stage4
2.067000E-01
Stage2-vs-Stage3
1.757040E-01
Stage2-vs-Stage4
7.959400E-01
Stage3-vs-Stage4
4.262600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.081200E-01
Normal-vs-AfricanAmerican
1.845980E-01
Normal-vs-Asian
5.427600E-01
Caucasian-vs-AfricanAmerican
7.786800E-01
Caucasian-vs-Asian
9.169800E-01
AfricanAmerican-vs-Asian
7.099000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.997200E-01
Normal-vs-Female
2.921800E-01
Male-vs-Female
2.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.323200E-01
Normal-vs-Age(41-60Yrs)
7.345600E-01
Normal-vs-Age(61-80Yrs)
2.757000E-01
Normal-vs-Age(81-100Yrs)
2.126600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.458800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.379200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.403200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.237900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.270200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.483400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.911000E-01
Normal-vs-Daily Drinker
2.221200E-01
Normal-vs-Weekly Drinker
3.957200E-01
Normal-vs-Occasional Drinker
6.626200E-01
Normal-vs-Social Drinker
1.405630E-01
Non Drinker-vs-Daily Drinker
4.802200E-01
Non Drinker-vs-Weekly Drinker
7.385600E-01
Non Drinker-vs-Occasional Drinker
3.009000E-01
Non Drinker-vs-Social Drinker
8.029800E-01
Daily Drinker-vs-Weekly Drinker
8.000200E-01
Daily Drinker-vs-Occasional Drinker
6.486100E-02
Daily Drinker-vs-Social Drinker
5.285800E-01
Weekly Drinker-vs-Occasional Drinker
2.173000E-01
Weekly Drinker-vs-Social Drinker
8.525600E-01
Occasional Drinker-vs-Social Drinker
1.213620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.934800E-01
Normal-vs-Grade 2
7.927400E-01
Normal-vs-Grade 3
7.652600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.419600E-02
Grade 1-vs-Grade 3
2.557900E-02
Grade 1-vs-Grade 4
8.934800E-01
Grade 2-vs-Grade 3
4.493400E-01
Grade 2-vs-Grade 4
7.927400E-01
Grade 3-vs-Grade 4
7.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.002200E-01
Normal-vs-NonDiabetic
4.431400E-01
Diabetic-vs-NonDiabetic
2.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.131200E-01
Normal-vs-NoPancreatitis
3.496600E-01
Pancreatitis-vs-NoPancreatitis
2.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.165400E-01
Normal-vs-N1
4.891200E-01
N0-vs-N1
3.933200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.681400E-01
Normal-vs-TP53-NonMutant
2.575000E-01
TP53-Mutant-vs-TP53-NonMutant
4.8833000000359E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
